Pharmaceutical Industry Articles & Reports - Page 21

Explore the root causes of biotech data silos and fragmentation. Learn how to implement FAIR standards and modern data infrastructure in life sciences R&D.

This analysis explains why restricted full-text access and scholarly paywalls are the primary barriers to developing accurate AI tools for research papers.

This article explains how artificial intelligence, advanced OCR, and LLMs extract unstructured clinical research and CRO data from complex PDF documents.

Examine the pharmaceutical AI strategy roadmap for scaling digital transformation. Learn about enterprise data infrastructure, LLMOps, and GxP compliance.

An in-depth 2026 LIMS software comparison analyzing LabWare, STARLIMS, LabVantage, and Sapio Sciences. Review core features, architectures, and lab use cases.

Review the evolving FDA regulatory framework for AI/ML SaMD. This guide explains PCCPs, total product lifecycle management, and 2026 compliance standards.

Review AI patient recruitment platforms for clinical trials. Compare EHR integration, federated networks, and patient-facing software for trial matching.

Examine top pharma AI consulting firms and life sciences vendors. This 2026 evaluation guide analyzes market trends, FDA regulations, and AI capabilities.

A comprehensive guide to decentralized clinical trials (DCTs). Review hybrid trial technologies, compare software platforms, and explore implementation steps.

Compare leading electronic data capture (EDC) systems for clinical trials. Analyze features of Medidata Rave, Veeva Vault, Castor, and Oracle Clinical One.

Examine how AI and real-time quality monitoring ensure GMP compliance in pharmaceutical manufacturing. Review machine learning frameworks and FDA guidelines.

A guide to FDA regulatory pathways for AI/ML SaMD. Compare 510(k), De Novo, and PMA submission requirements for artificial intelligence medical devices.

Examine how agentic AI automates pharmaceutical regulatory documents like CSRs, NDAs, and eCTD workflows while managing compliance and validation risks.

Learn how to quantify AI ROI in pharmacovigilance. This guide analyzes cost drivers, payback periods, and metrics for automating PV case processing workflows.

Learn why 95% of pharma AI pilots fail to reach production. This guide explains PoC failure causes, data integration challenges, and strategies for scaling.

Explore pharma AI change management and organizational readiness strategies. Understand how life science companies build AI literacy to address skills gaps.

Examine how digital twins in clinical trials function as virtual control arms. This report reviews FDA guidance, AI models, and implementation requirements.

Review the FDA's 7-step AI credibility assessment framework. Understand how to validate and document AI models for regulatory drug development submissions.

Examine the technical and operational factors of CDMS replacement. Compare legacy SAS systems with modern cloud EDC platforms in clinical data management.

Learn how agentic AI in pharma transitions from pilot stages to production. Explore autonomous multi-agent systems, clinical use cases, and regulatory impacts.

Learn how Biobank LIMS software manages specimen tracking, chain-of-custody, and complex data architecture. Compare leading BIMS solutions for biorepositories.

Review how modern CTMS dashboards track clinical trial KPIs. This guide explains operational metrics for enrollment, site performance, and data management.

Examine why most pharma AI pilots fail to reach production. This report analyzes data fragmentation, governance issues, and building scalable data foundations.

A 2026 evaluation framework for selecting pharma AI consulting firms. Review vendor criteria including regulatory compliance, data governance, and AI expertise.